BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31385269)

  • 1. Antimicrobial Resistance Screening in Chlamydia trachomatis by Optimized McCoy Cell Culture System and Direct qPCR-Based Monitoring of Chlamydial Growth.
    Meštrović T; Virok DP; Ljubin-Sternak S; Raffai T; Burián K; Vraneš J
    Methods Mol Biol; 2019; 2042():33-43. PubMed ID: 31385269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dynamic range detection of Chlamydia trachomatis growth by direct quantitative PCR of the infected cells.
    Eszik I; Lantos I; Önder K; Somogyvári F; Burián K; Endrész V; Virok DP
    J Microbiol Methods; 2016 Jan; 120():15-22. PubMed ID: 26578244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of
    Mestrovic T; Ljubin-Sternak S
    Front Biosci (Landmark Ed); 2018 Jan; 23(4):656-670. PubMed ID: 28930567
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimicrobial Sensitivity Profile of Chlamydia trachomatis isolates from Croatia in McCoy Cell Culture System and Comparison with the Literature.
    Mestrović T; Ljubin-Sternak S; Sviben M; Bedenić B; Vranes J; Markotić A; Skerk V
    Clin Lab; 2016; 62(3):357-64. PubMed ID: 27156324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.
    Wang SA; Papp JR; Stamm WE; Peeling RW; Martin DH; Holmes KK
    J Infect Dis; 2005 Mar; 191(6):917-23. PubMed ID: 15717267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clinically relevant culture conditions on antimicrobial susceptibility of Chlamydia trachomatis.
    Wyrick PB; Davis CH; Raulston JE; Knight ST; Choong J
    Clin Infect Dis; 1994 Nov; 19(5):931-6. PubMed ID: 7893882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibilities of Chlamydia trachomatis isolated from the urethra and pharynx of Japanese males.
    Kai S; Wada K; Sadahira T; Araki M; Ishii A; Watanabe T; Monden K; Uno S; Araki T; Nasu Y
    J Infect Chemother; 2017 Aug; 23(8):512-516. PubMed ID: 28476331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Throughput Screening for Novel Inhibitors of Intracellular Pathogens, Including Chlamydia trachomatis.
    Brown AC; Kushner NL
    Methods Mol Biol; 2019; 2042():279-286. PubMed ID: 31385282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the Mitochondrion-Fatty Acid Axis for the Metabolic Reprogramming of Chlamydia trachomatis during Treatment with β-Lactam Antimicrobials.
    Shima K; Kaufhold I; Eder T; Käding N; Schmidt N; Ogunsulire IM; Deenen R; Köhrer K; Friedrich D; Isay SE; Grebien F; Klinger M; Richer BC; Günther UL; Deepe GS; Rattei T; Rupp J
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis.
    Bowie WR; Lee CK; Alexander ER
    J Infect Dis; 1978 Nov; 138(5):655-9. PubMed ID: 712119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-cell western assay as a high-throughput approach for Chlamydia trachomatis quantification and susceptibility testing to antimicrobials.
    Filardo S; Di Pietro M; Pasqualetti P; Manera M; Diaco F; Sessa R
    PLoS One; 2021; 16(5):e0251075. PubMed ID: 33974662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
    Mpiga P; Ravaoarinoro M
    Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.
    Dreses-Werringloer U; Padubrin I; Zeidler H; Köhler L
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3001-8. PubMed ID: 11600348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infections.
    Pitt R; Alexander S; Ison C; Horner P; Hathorn E; Goold P; Woodford N; Cole MJ
    J Antimicrob Chemother; 2018 Mar; 73(3):680-686. PubMed ID: 29207004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of antiseptics on Chlamydia trachomatis growth.
    Párducz L; Eszik I; Wagner G; Burián K; Endrész V; Virok DP
    Lett Appl Microbiol; 2016 Oct; 63(4):260-7. PubMed ID: 27472980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan.
    Takahashi S; Hamasuna R; Yasuda M; Ishikawa K; Hayami H; Uehara S; Yamamoto S; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sato J; Hanaki H; Masumori N; Kiyota H; Egawa S; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Wada K; Kobayashi K; Matsubara A; Matsumoto T; Eto M; Tatsugami K; Kuroiwa K; Ito K; Hosobe T; Hirayama H; Narita H; Yamaguchi T; Ito S; Sumii T; Kawai S; Kanokogi M; Kawano H; Chokyu H; Uno S; Monden K; Kaji S; Kawahara M; Takayama K; Ito M; Yoshioka M; Kano M; Konishi T; Kadena H; Nishi S; Nishimura H; Yamauchi T; Maeda S; Horie M; Ihara H; Matsumura M; Shirane T; Takeyama K; Akiyama K; Takahashi K; Ikuyama T; Inatomi H; Yoh M
    J Infect Chemother; 2016 Sep; 22(9):581-6. PubMed ID: 27452428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determining antimicrobial resistance to Chlamydia trachomatis and applying present findings in daily practice].
    Sternak SL; Skerk V
    Med Glas (Zenica); 2010 Feb; 7(1):26-31. PubMed ID: 20387721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Chlamydial infections: 2014 update.
    Kohlhoff SA; Hammerschlag MR
    Expert Opin Pharmacother; 2015 Feb; 16(2):205-12. PubMed ID: 25579069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Chlamydia trachomatis to the excipient hydroxyethyl cellulose: pH and concentration dependence of antimicrobial activity.
    Sater AA; Ojcius DM; Meyer MP
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2660-2. PubMed ID: 18411317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of urogenital Chlamydia trachomatis strains in a country with high azithromycin consumption rate.
    Ljubin-Sternak S; Mestrovic T; Vilibic-Cavlek T; Mlinaric-Galinovic G; Sviben M; Markotic A; Skerk V
    Folia Microbiol (Praha); 2013 Sep; 58(5):361-5. PubMed ID: 23271498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.